While the compound’s in vitro exercise is not really laid out in the patent, anecdotal evidence suggests It's really a potent cannabinoid agonist having an active dose of about 0.1mg.It isn't intended for human consumption but fairly for investigating the pharmacological results, likely therapeutic applications, and safety profiles of artificial